Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours

BACKGROUND: Most gastrointestinal stromal tumours (GIST) are driven by activating oncogenic mutations of KIT/PDGFRA, which provide a compelling therapeutic target. Our previous studies showed that CDC37, regulated by casein kinase 2 (CK2), is a crucial HSP90 cofactor for KIT oncogenic function and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Mengyuan, Yang, Wenyu, Zhu, Jiaqing, Mariño-Enríquez, Adrián, Zhu, Chennianci, Chen, Jiaming, Wu, Yuehong, Quan, Yanping, Qiu, Haibo, Li, Xuhui, Chai, Li, Fletcher, Jonathan A., Ou, Wen-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000686/
https://www.ncbi.nlm.nih.gov/pubmed/31776458
http://dx.doi.org/10.1038/s41416-019-0657-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000686/
https://www.ncbi.nlm.nih.gov/pubmed/31776458
http://dx.doi.org/10.1038/s41416-019-0657-5

Ejemplares similares